D,L-聚乳酸-聚乙二醇嵌段共聚物微球防龋基因疫苗的体外研究

目的 制备防龋基因疫苗的DNA／PEIA微球,并研究其在真核细胞中的表达情况。方法采用改进的溶剂挥发法双乳液(W1/O／W2)体系制备基因疫苗的DNA／PELA微球;测定了微球的形态大小、包封率及细胞毒性,将基因疫苗微球转染哺乳动物细胞,用流式细胞仪和RT-PCR测定在其中表达的情况。结果制备的DNA／PELA复合物多呈球状,平均粒径1．806μm,对细胞无毒性,可在体外转染哺乳动物细胞,并能正确地转录表达;结果证实基因疫苗微球转染效率低,提示微球中的DNA具有缓慢释放的特征。结论PEIA可作为防龋基因疫苗的投递系统,是一种安全、有效的释放体系。     

一种可生物降解温度敏感型聚乙二醇-聚己内酯-聚乙二醇水凝胶的合成和表征

合成了一系列分子量较低的聚乙二醇．聚己内酯-聚乙二醇（Poly（ethylene glycol）-Polycaprolactone-Poly（ethylene glycol），PEG-PCL—PEG）三嵌段共聚物。分别采用FTIR和1H—NMR对其结构进行了表征。所合成的PEG-PCL-PEG共聚物具有良好的水溶性，当水溶液浓度高于临界凝胶浓度（Critical gel concentration，CGC）时，随着温度的变化聚合物水溶液会呈现特有的凝胶-溶胶转变。研究了共聚物亲水疏水链段的比例和长度，以及热历史等对凝胶-溶胶转变行为的影响。通过调节上述条件，可以在一定程度上拓宽凝胶-溶胶转变温度范围，有助于PEG—PCL-PEG水凝胶在可注射药物控制释放系统等方面的应用。     

聚乳酸/聚乙二醇-聚乳酸新型亲水支架的制备与研究

利用热致相分离/粒子沥滤结合法,制备了聚乳酸(PDLLA)以及聚乳酸与聚乙二醇-聚乳酸共聚物(PELA)复合的PDLLA/PELA组织工程支架。讨论了聚乙二醇(PEG)分子量、PELA含量及组成比对于支架内部结构、力学性能、降解行为和细胞毒性的影响。结果表明,热致相分离/粒子沥滤结合法制备的支架,具有100~250μm大孔与5~40μm小孔兼备的特殊内部结构,PEG含量愈高、PEG分子量愈小,支架的孔隙率愈大。PDLLA/PELA比率的减小,PEG/PLA比率的增大会引起支架力学性能的下降和降解的加速。材料无细胞毒性。当支架中PDLLA/PELA为3∶1,PEG 5000/PLA为25∶75时,其内部孔形态最为理想。     

PELA作为防龋基因疫苗投递系统的体外研究

为了解聚乳酸 -聚乙二醇共聚物(PELA)作为防龋基因疫苗的投递系统的可行性、有效性和安全性 ,作者用PELA包被本室构建的防龋基因疫苗pEGFPC1 pacA ,对DNA/PELA微球制备方法、微球特征以及体外转染进行了初步研究。微球采用改进的溶剂挥发法双乳液(W1/O/W2 )体系制备。 1.0 5mg/ml高纯度的重组质粒pEGFPC1 pacA水溶液作为内水相W1,PELA的二氯甲烷溶液作为油相O ,2 .0 %的PVA溶液作为外水相W2。用溶剂抽提法 (5 %的异丙醇水溶基金项目 :国家自然科学基金 ( 2 0 0 40 0 9) ;973项目作者单位 :610 0 41成都 ,四川大学华西基础医…     

包裹E1A基因的纳米粒子制备及转染人肺腺癌细胞A549实验研究

目的制备包裹E1A基因（腺病毒早期表达基因）的纳米粒子,并观察其介导E1A基因转染人肺腺癌细胞A549的可行性和效率。方法应用聚乳酸聚乙醇酸共聚物和聚乙烯醇包载E1A基因,制备纳米级粒子混合物,检测其包埋率、体外释放情况及粒径大小。用制备的包裹DNA纳米粒子转染人肺腺癌细胞A549,并以阳离子脂质体为对照,用PCR、RT-PCR方法分别检测转染细胞中E1A基因DNA整合和mRNA表达。结果制备的纳米粒子粒径为150～280nm,包埋率为0.78%,体外释放约为22d;在转染相等质量的DNA情况下,纳米组所得克隆数较脂质体组多（P〈0.05）;PCR、RT-PCR结果表明纳米粒子和脂质体转染细胞均有E1A基因整合和mRNA表达。结论成功制备了纳米粒子,纳米粒子可携带外源基因进行基因转染。     

聚乙二醇对利福平-聚乳酸-羟基乙酸聚合物缓释微球性能的影响

背景：聚乳酸-羟基乙酸共聚物微球具有良好的生物相容性,是优良的药物缓释载体,但缓释微球的突释问题严重影响了其临床应用。 目的：观察聚乙二醇对利福平-聚乳酸-羟基乙酸聚合物缓释微球特征、载药率、包封率、体外释放规律及突释的影响。 方法：以高分子材料聚乳酸-羟基乙酸共聚物作为载体,采用复乳化-溶剂挥发法制备聚乙二醇-利福平-聚乳酸-羟基乙酸聚合物微球(实验组)和利福平-聚乳酸-羟基乙酸聚合物微球(对照组)。扫描电子显微镜观察两组聚合物缓释微球特征,高效液相色谱法检测两组微球在不同时段模拟体液中的利福平药物浓度及累计释放量,计算两组微球的载药量、包封率。 结果与结论：与对照组比较,实验组微球表面光滑、粒径减小、分散良好,包封率和载药量明显提高。实验组微球3 h内药物释放量最大,1 d左右药物释放趋于平稳稳定状态,1 d药物累计释放量小于20%;对照组微球3 h内药物释放量最大,约为实验组的1.5倍,1 d左右药物释放也趋于平稳状态。表明聚乙二醇可改善利福平-聚乳酸-羟基乙酸聚合物缓释微球的成球率,减小其粒径,增加其载药量和包封率,控制其突释现象。 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程全文链接：     

影响微球药物释放因素的研究

目的 观察影响微球药物释放的因素，为其应用提供理论基础。方法 以可生物降解的聚乳酸—聚乙醇酸共聚物(PLGA)和聚L—乳酸(PLIA)为载体，采用乳化—溶剂挥发法制备含细胞松弛素B(cytoB)微球，以HPLC测定cy-toB含量。结果 制备了不同球径的微球，其球径分别为150nm、500nm、1μm、5μm、10μm和20μm。体外释放实验证明，球径越小，药物释放速度越快；球径相同时，以PLIA为基材的微球比PLGA的释放慢。结论 可通过选择适当的微球大小和基质材料达到所期望的药物释放过程。     

PELA幽门螺杆菌口服疫苗微球黏膜免疫研究

目的：应用复乳挥发法制备PELA泛影葡胺显影微球与缨门螺杆菌超声上清口服疫苗微球，并进行靶向与黏膜免疫研究。方法：采用CT技术，研究显影微球的靶向，PELA幽门曙杆菌超声上清口服疫苗微球口服免疫小鼠后，运用ELISA法检测血清，唾液，肠粘液的抗体改变情况，ELISPOT法分析派伊尔氏结（PP结）抗原特异性抗体形成细胞（ASC）的数量增减，结果；口粒径在10um以下的微球，首先粘附在胃肠黏膜表面，后投递于PP结；H.pylori疫苗微球免疫后可诱导较高的唾液sIgA水平和肠道sIgA反应，PP结抗原特异性抗体形成细胞（ASC）数量与肠道 sIgA水平密切相关，结论：可生物降解的PELA微球可用于靶向口服疫苗的研究。     

聚乳酸-聚乙二醇共聚物的生物学效应研究

目前报道最多用于药物控释系统的载体材料是聚乳酸（PLA）及其共聚物聚乳酸-聚乙醇酸（PL-GA）。它们虽然生物相容性好，降解产物可被人体代谢吸收，也是FDA批准可用于人体的生物降解材料，但存在疏水性太强，对亲水性药物的亲合力弱导致包裹效率低，药物的活性易遭到破坏等缺点。     

表皮生长因子微球的制备与评价

目的制备表皮生长因子（EGF）微球并对其生物学活性进行评价。方法利用改进的复乳法．以聚乳酸,羟基乙酸共聚物（PLGA）作为载体,制备EGF微球。检测EGF微球形貌表征、微球粒径分布、载药率、包封率和释药行为。用噻唑蓝（MTr）法测定增殖度,研究不同浓度EGF微球对细胞增殖能力的影响,研究相同浓度不同剂型EGF对细胞增殖的影响．研究微球载体的安全性。结果EGF微球粒径约为200nm,粒径分布比较均一,微球之间无粘连,分散性好。载药率为0．02％．包封率为85％。释药符合释放动力学模型,释放长达24h。不同浓度EGF微球均促进细胞增殖。其中10μg／L为最适质量浓度（与对照组EE,P〈0．01）。质量浓度10μg/L时,EGF微球组与EGF原液组相比差异有统计学意义（P〈0．01）。不同质量浓度空微球对细胞没有毒性,不影响细胞增殖（组间没有差异,P〉0．05）。结论成功制备EGF微球。细胞实验证明EGF微球制备过程中EGF保持原有活性。与EGF原液比较．EGF微球促进细胞增殖能力更强,微球载体对细胞没有毒性作用。     

Core-sheath structured fibers with pDNA polyplex loadings for the optimal release profile and transfection efficiency as potential tissue engineering scaffolds

Emulsion electrospinning was initially applied to prepare core-sheath structured fibers with a core loading of pDNA or pDNA polyplexes inside a fiber sheath of poly(DL-lactide)-poly(ethylene glycol) (PELA). The inclusion of poly(ethylene imine) (PEI) and poly(ethylene glycol) (PEG) were expected to modulate the release profiles and achieve a balance between cytotoxicity and transfection efficiency. The core-sheath fibers enhance the structural integrity and maintain the biological activity of pDNA during the electrospinning process, incubation in release buffer and enzyme digestion. The addition of hydrophilic PEI into the fiber matrix accelerates pDNA release, while the encapsulation of pDNA polyplexes within the fibers led to no further release after an initial burst. However, sustained release of pDNA polyplexes has been achieved through PEG incorporation, and the effective release lifetime can be controlled between 6 and 25 days, dependent on the amount loaded and the molecular weight of PEG. Higher N/P ratios of PEI to DNA result in lower cell attachment, while cell viability is dependent on the effective concentration of pDNA polyplexes released from the fibers. While no apparent transfection is detected for pDNA-loaded PELA fibers, PEG incorporation into fibers containing pDNA polyplexes leads to over an order of magnitude increase in the transfection efficiency. pDNA polyplex-loaded fibers containing 10% PEG show the best performance in balancing transfection efficiency and cell viability. It is suggested that electrospun core-sheath fibers integrated with DNA condensation techniques provide the potential to produce inductive tissue engineering scaffolds able to manipulate the desired signals at effective levels within the local tissue microenvironment.     

The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection

Cationic micelles self-assembled from a biodegradable amphiphilic copolymer, poly{(N-methyldietheneamine sebacate)-co-[(cholesteryl oxocarbonylamido ethyl) methyl bis(ethylene) ammonium bromide] sebacate} (P(MDS-co-CES)) have recently been reported for efficient gene delivery and co-delivery of drug and nucleic acid. In this study, poly(ethylene glycol) (PEG) of various molecular weights (Mn=550, 1100 and 2000) was conjugated to P(MDS-co-CES) having different cholesterol grafting degrees to improve the stability of micelle/DNA complexes in the blood for systemic in vivo gene delivery. DNA binding ability, gene transfection efficiency and cytotoxicity of P(MDS-co-CES), PMDS, PEGylated PMDS and PEGylated P(MDS-co-CES) micelles were studied and compared. As with P(MDS-co-CES), PEG-P(MDS-co-CES) polymers could also self-assemble into stable micelles of small size. However, PMDS and PEG-PMDS without cholesterol could not form stable micelles but formed large particles. PEGylation of polymers significantly decreased their gene transfection efficiency in HEK293, HepG2, HeLa, MDA-MB-231 and 4T1 cells. However, increasing N/P ratio promoted gene transfection. An increased cholesterol grafting degree led to greater gene expression level possibly because of the more stable core-shell structure of the micelles. PEG550-P(MDS-co-CES) micelles induced high gene transfection level, comparable to that provided by P(MDS-co-CES) micelles. PEGylated polymers were much less cytotoxic than P(MDS-co-CES). PEGylated P(MDS-co-CES) micelles may provide a promising non-viral vector for systemic in vivo gene delivery.     

Manipulations in hydrogel chemistry control photoencapsulated chondrocyte behavior and their extracellular matrix production

In engineering a cell-carrier to support cartilage growth, hydrogels provide a unique, largely aqueous environment for 3-dimensional chondrocyte culture that facilitates nutrient transport yet provides an elastic framework dictating tissue shape and supporting external loads. Although the gel environment is often >90% water, we demonstrate that slight variations in hydrogel chemistry control gel degradation, evolving macroscopic properties, and ultimately the secretion and distribution of extracellular matrix molecules. Specifically, biodegradable poly(ethylene glycol)-co-poly(lactic acid) hydrogels were fabricated via photopolymerization. When chondrocytes were photoencapsulated in these gels, changes in the poly(ethylene glycol)-co-poly(lactic acid) repeat unit ratio from 19 to 7 increased total collagen synthesis 2.5-fold after 6 weeks in vitro. Furthermore, the ratio of collagen to glycosaminoglycans varied from glycosaminoglycan-rich, 0.33 +/- 0.13, to collagen-rich, 4.58 +/- 1.21, depending on gel chemistry and in vitro versus in vivo culture environment. By tuning scaffold chemistry, and subsequently, gel structure and degradation behavior, we can better guide tissue evolution and development.     

Development of amine-containing polymeric particles

The objective of this study was to synthesize and characterize particles as a drug-delivery platform for gliomas, a highly advanced and invasive stage of brain tumor with poor prognosis. Poly(aminoethyl methacrylate-co-methyl methacrylate) particles were prepared by suspension polymerization and poly(aminoethyl methacrylate-co-poly(ethylene glycol) methacrylate) particles were prepared by emulsion (w/o) polymerization. Amine groups of the particles were complexed with tetrachloroplatinate to form a cisplatin-like molecule. Particles were characterized with respect to size, zeta-potential, amine content, loading efficiency and drug release. Poly(aminoethyl methacrylate-co-methyl methacrylate) particles had diameters of below 10 microm, whereas the poly(aminoethyl methacrylate-co-poly(ethylene glycol) methacrylate) particles had diameters of approx. 1 microm. Poly(aminoethyl methacrylate-co-poly(ethylene glycol) methacrylate) particles had a more positive zeta-potential as compared to poly(aminoethyl methacrylate-co-methyl methacrylate) particles, although the amino-group content of both particles was almost equivalent. The net positive charge on the particles decreased after complexation with tetrachloroplatinate for both types of particles. Both particles had very high platinum-loading efficiency (>85%) and showed slow release of platinum over time. Particles had relatively low cytotoxicity (LC50 > 100 microg/ml) and demonstrated a high degree of association with cells. Complexation with poly(aminoethyl methacrylate-co-methyl methacrylate) particles significantly reduced the toxicity of platinum. The poly(aminoethyl methacrylate-co-poly(ethylene glycol) methacrylate) particles have potential for being an effective drug-delivery platform and continued investigation is warranted.     

Fabrication and characterization of hydrophilic electrospun membranes made from the block copolymer of poly(ethylene glycol-co-lactide)

To improve the hydrophilicity, pliability, and egradability of some biodegradable polymers such as polylactide (PLA), a triblock copolymer, and poly(ethylene glycol-co-lactide) (PELA) has been electrospun into fibrous membranes in the fiber sizes of 7.5 microm to 250 nm. The relationship between electrospinning parameters (such as voltage, concentration, and feeding rate) and the fiber diameters has been investigated. The characterizations for the structure and morphology of electrospun membranes were carried out using differential scanning calorimetry (DSC), (1)H NMR, and scanning electron microscopy (SEM). The hydrophilicity of the membrane was determined by contact angle measurements in bi-distilled water, and it was shown that the hydrophilicity of the copolymer could be adjusted by the content of the poly (ethylene glycol) (PEG) segment in the copolymer. The results of in vitro degradation study showed that the submicrostructure of the fibrous membrane and the incorporation of hydrophilic PEG into PLA block could accelerate the degradation of the membrane in regards to the changes of inherent viscosity, tensile strength, and weight loss.     

PEGylated guanidinylated polyallylamine as gene-delivery carrier

A novel cationic co-polymer was developed by grafting poly(ethylene glycol) (PEG) on guanidinylated polyallylamine (PAA) for gene delivery. Characterization of PEG-g-guanidinylated PAA/DNA complexes demonstrated that particle size increased and surface charge decreased with increasing the amount of PEG. The results of cytotoxicity assay proved that grafted PEG could effectively decrease the cytotoxicity of the complexes. In transfection efficiency assay, HeLa cells treated with PEG(2)-g-guanidinylated PAA (formed with 17.5 μmol guanidinylated PAA and 2 μmol PEG)/DNA (0.2 μg EGFP plasmid) complexes showed a very high level of EGFP expression. In conclusion, combination of guanidinylation and PEGylation could effectively decrease the cytotoxicity and significantly increase the transfection efficiency of PAA.     

Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery

A major challenge in gene therapy is the development of effective gene delivery vectors with low toxicity. In the present study, linear poly(ethylenimine) (lPEI) with low molecular weight was grafted onto the block copolymer (PPL) of poly(l-lysine) (PLL) and poly(ethylene glycol)(PEG), yielding a ternary copolymer PEG-b-PLL-g-lPEI (PPI) for gene delivery. In such molecular design, PLL, lPEI and PEG blocks were expected to render the vector biodegradability, proton buffering capacity, low cationic toxicity and potentially long circulation in vivo, respectively. Given proper control of molecular composition, the copolymers demonstrated lower cytotoxicity, proton buffering capacity, ability to condense pDNA and mediate effective gene transfection in various cell lines. With folate as an exemplary targeting ligand, the FA-PPI/pDNA complex showed much higher transgene activity than its nontargeting counterpart for both reporter and therapeutic genes in folate receptor(FR)-positive cells. FA-PPI mediated effective transfection of the TNF-related apoptosis-inducing ligand gene (TRAIL) in human hepatoma Bel 7402 cells, leading to cell apoptosis and great suppression of cell viability. Our results indicate that the copolymers might be a promising vector combining low cytotoxicity, biodegradability, and high gene transfection efficiency.     

Pentablock copolymers of poly(ethylene glycol), poly((2-dimethyl amino)ethyl methacrylate) and poly(2-hydroxyethyl methacrylate) from consecutive atom transfer radical polymerizations for non-viral gene delivery

Well-defined pentablock copolymers (PBPs) of P(HEMA)-b-P(DMAEMA)-b-PEG-b-P(DMAEMA)-b-P(HEMA) (in which PEG = poly(ethylene glycol), P(DMAEMA) = poly((2-dimethyl amino)ethyl methacrylate), and P(HEMA) = poly(2-hydroxyethyl methacrylate)), with different block lengths of P(DMAEMA), for non-viral gene delivery were prepared via consecutive atom transfer radical polymerizations (ATRPs) from the same di-2-bromoisobutyryl-terminated PEG (Br–PEG–Br) center block. The PBPs demonstrate good ability to condense plasmid DNA (pDNA) into 100–160 nm size nanoparticles with positive zeta potentials of 25–35 mV at PBPs/pDNA weight ratios of 5–25. The PBPs exhibit very low in vitro cytotoxicity and excellent gene transfection efficiency in HEK293 and COS7 cells. In particular, the transfection efficiencies of all the PBPs in HEK293 cells are comparable to, or higher than those of polyethylenimine (PEI, 25 kDa) at most weight ratios. The ability of the copolymers to condense plasmid DNA and the transfection efficiency of the resulting complexes are dependent on the chain length of P(DMAEMA) blocks. In addition to reducing the cytotoxicity and increasing the stability of the plasmid complexes, the PEG center block and the short P(HEMA) end blocks also help to enhance the gene transfection efficiency. Thus, the approach to well-defined block copolymers via ATRP provides a versatile means for tailoring the structure of non-viral gene vectors to meet the requirements of low cytotoxicity, good stability and high transfection capability for gene therapy applications.     

Cell viability of chitosan-containing semi-interpenetrated hydrogels based on PCL-PEG-PCL diacrylate macromer

Chitosan-modified biodegradable hydrogels were prepared by UV irradiation of solutions in mild aqueous acidic media of poly(caprolactone)-co-poly(ethylene glycol)-co-poly(caprolactone) diacrylate (PCL-PEG-PCL-DA) and chitosan. Hydrogels obtained were characterized using FT-IR, DSC, TGA and XPS. FT-IR, TGA and DSC revealed the semi-interpenetrating polymer network structure formed in the hydrogel. Though the water swelling degree of these chitosan-modified hydrogels was substantial in the range of 322-539%, it was found that fibroblasts could still attach, spread and grow on them; this is in contrast to the commonly investigated PEG-diacrylate hydrogel. The MTT assay demonstrated that cells could grow better on 3 or 6% chitosan-modified hydrogel than unmodified PCL-PEG-PCL-DA hydrogels or low-content (1%) chitosan-modified PCL-PEG-PCL-DA hydrogel. Increased chitosan content resulted in increased cell interaction and also decreased water swelling, both of which results in increased cell attachment and spread.     

PEGylated Guanidinylated Polyallylamine as Gene-Delivery Carrier

A novel cationic co-polymer was developed by grafting poly(ethylene glycol) (PEG) on guanidinylated polyallylamine (PAA) for gene delivery. Characterization of PEG-g-guanidinylated PAA/DNA complexes demonstrated that particle size increased and surface charge decreased with increasing the amount of PEG. The results of cytotoxicity assay proved that grafted PEG could effectively decrease the cytotoxicity of the complexes. In transfection efficiency assay, HeLa cells treated with PEG(2)-g-guanidinylated PAA (formed with 17.5 μmol guanidinylated PAA and 2 μmol PEG)/DNA (0.2 μg EGFP plasmid) complexes showed a very high level of EGFP expression. In conclusion, combination of guanidinylation and PEGylation could effectively decrease the cytotoxicity and significantly increase the transfection efficiency of PAA.